Galvany Pharma Limited

  • Small
  • Active
  • 3 years
  • £1,987,243 (assets)
  • Virtual address
  • 4 directors
  • No owners
  • Regular importer

Field of Operation

Manufacture of basic pharmaceutical products
21100 1484 companies
Manufacture of pharmaceutical preparations
21200 863 companies
Research and experimental development on biotechnology
72110 5951 companies

Website

Social media

Summary

Galvany Pharma Limited is a small, active pharmaceutical company based in Stevenage, UK, founded three years ago in March 2022. With £1,987,243 in assets, it operates from a virtual address – thirty-one companies share the same location – and is managed by four directors, though no owners are officially listed. The company regularly imports pharmaceutical products, with recent activity recorded in December 2024.

The company’s website highlights Galvany Pharma as a UK-based firm specializing in the development and commercialization of niche pharmaceuticals. It boasts a portfolio of high-quality products targeting unmet clinical needs and aims to provide affordable medicines. Galvany leverages strategic partnerships with European and global manufacturers and has a direct presence in the UK alongside several commercial partnerships, enabling a global reach. The company’s leadership team emphasizes integrity, customer focus, and operational excellence. Recent news includes participation in the Current Issues in Palliative Care event and the launch of Levorol 6.25mg tablets.

Financially, Galvany Pharma’s situation presents a mixed picture. Cash reserves decreased by 31%, falling to £680,000, while creditors dramatically increased by 2000%, reaching £110,000. Current assets remained relatively stable at £2,000,000, but equity experienced a significant drop of 480%, resulting in a negative balance of -£120,000. Trade debtors have also increased considerably, by 410%. The company meets the criteria for a small business, with turnover under £10.2 million, assets under £5.1 million, and fewer than 50 employees. The lack of an auditor is consistent with its status as a small company.

Overall, Galvany Pharma appears to be facing some financial challenges, with a significant drop in equity and increased liabilities. While its focus on niche pharmaceuticals and strategic partnerships suggests potential for growth, the company will need to manage its finances carefully to ensure its long-term sustainability.

Registered in England/Wales under the registration number 13977261, with a registered address at SG1 2DX, England, Stevenage, Business & Technology Centre, Bessemer Drive.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.

Managers

  • 3 years
  • 1
Operations director
  • 3 years
  • 2
Chief executive officer
  • 3 years
  • 2
Secretary
  • 3 years
  • 3
Chairman

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Confirmation statement made on 2025-03-06 with updates
  2. Director's details changed for Steven Charles Andrew Harris on 2025-03-01
  3. Director's details changed for Mr Graham Robert Smith on 2025-03-01
See all events

Galvany Pharma Limited controls

Owns & Controls

  • 2 years
  • 75%+

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

Similar importers

Buy the list of 577 UK B2B buyers of pharmaceutical products.
  • Company names
  • HS codes
  • Financial data
  • Officers and owners
*from 99$

FAQ about Galvany Pharma Limited

Looking for leads in the UK?

Try our FREE App—access UK datasets with limited features!

Similar companies